IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALBERICI, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.374
EU - Europa 915
AS - Asia 554
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 5
SA - Sud America 3
Totale 3.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.355
HK - Hong Kong 217
UA - Ucraina 215
IT - Italia 183
CN - Cina 178
GB - Regno Unito 123
DE - Germania 106
SG - Singapore 106
IE - Irlanda 78
FI - Finlandia 69
PL - Polonia 42
RU - Federazione Russa 41
TR - Turchia 17
CA - Canada 15
CZ - Repubblica Ceca 13
DZ - Algeria 12
FR - Francia 12
BE - Belgio 10
EU - Europa 9
JP - Giappone 8
SE - Svezia 8
IR - Iran 7
IN - India 5
VN - Vietnam 5
AU - Australia 4
MX - Messico 4
CH - Svizzera 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
ES - Italia 2
ID - Indonesia 2
IL - Israele 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
GE - Georgia 1
KR - Corea 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SD - Sudan 1
ZA - Sudafrica 1
Totale 3.875
Salva come PNG Salva come JPEG
Città #
Fairfield 420
Woodbridge 225
Hong Kong 216
Ashburn 201
Houston 180
Jacksonville 176
Seattle 164
Wilmington 154
Cambridge 151
Princeton 145
Beijing 83
Dublin 76
New York 75
Chandler 72
Ann Arbor 70
Helsinki 63
Singapore 58
Warsaw 38
San Diego 37
Des Moines 29
Brescia 28
Shanghai 24
Toronto 13
Brno 12
Algiers 11
Kocaeli 11
London 11
Brussels 10
Frankfurt am Main 10
Milan 10
Jinan 9
Nanjing 8
Changsha 7
San Francisco 7
Ardabil 6
Lappeenranta 6
San Mateo 6
Shenyang 6
Washington 6
Augusta 5
Hebei 5
Leawood 5
Mantova 5
Tokyo 5
Cazzago San Martino 4
Centro Municipality 4
Chicago 4
Chiswick 4
Dearborn 4
Dong Ket 4
Fuzhou 4
Kilburn 4
Los Angeles 4
Lowicz 4
Norwalk 4
Tianjin 4
Verona 4
Zhengzhou 4
Albano Laziale 3
Bologna 3
Hounslow 3
Kunming 3
Nanchang 3
Ningbo 3
Parma 3
Yoshii 3
Allston 2
Atlanta 2
Barcelona 2
Bayreuth 2
Bedizzole 2
Brixen 2
Campodarsego 2
Canberra 2
Catania 2
Cinisello Balsamo 2
Colorno 2
Cremona 2
Dallas 2
Deiva Marina 2
Florence 2
Genoa 2
Genova 2
Goiânia 2
Groningen 2
Guangzhou 2
Hangzhou 2
Islington 2
Latina 2
Melbourne 2
Melzo 2
Modena 2
Monmouth Junction 2
Nordhastedt 2
Padova 2
Prescot 2
Redmond 2
Redwood City 2
Reston 2
Rome 2
Totale 3.007
Salva come PNG Salva come JPEG
Nome #
Genetics of ANCA-Associated Vasculitis 110
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis 110
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): A phase III, randomized, multicentre trial of the italian oncology group for clinical research (GOIRC) 84
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 78
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 78
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 77
Pneumocystis Jirevocii and SARS-CoV-2 co-infection: A common feature in transplant recipients? 77
A cross-sectional study of the Birmingham vasculitis activity score version 3 in systemic vasculitis 73
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 72
Impact of rituximab trials on the treatment of ANCA-associated vasculitis 71
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 71
Chronic periaortitis with thoracic aorta and epiaortic artery involvement: A systemic large vessel vasculitis? 70
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 70
Chronically administered immunotherapy with low-dose IL-2 and IFN-α in metastatic renal cell carcinoma: A feasible option for patients with a good prognostic profile 69
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 67
Update on ANCA-associated vasculitis: from biomarkers to therapy 67
The role of analytical methods for the determination of trace elements in environmental biomonitors 66
IgG4 immune response in Churg-Strauss syndrome 66
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease 65
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis 63
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: An open-label randomised controlled trial 63
Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis 63
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series 62
Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-α in patients with renal cell carcinoma 62
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC) 61
Orofacial granulomatosis treated with low-level laser therapy: A case report 61
PTPN22 R620W polymorphism in the ANCA-associated vasculitides 61
Peripheral inflammatory arthritis in patients with chronic periaortitis: Report of five cases and review of the literature 60
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia 60
Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index 58
FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome 57
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis 56
Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation 55
Lupus nephritis and B-cell targeting therapy 54
Chronic periaortitis associated with membranous nephropathy: Clues to common pathogenetic mechanisms 54
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy 54
Prevention of arterial thrombosis recurrence in anti-phospholipid syndrome: are anti-platelets the answer? 53
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients 50
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial 50
The Authors Reply 48
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience 45
FCGR3B polymorphism predicts relapse risk in eosinophilic granulomatosis with polyangiitis 43
[Managing patients in dialysis and with kidney transplant infected with Covid-19] 42
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 41
[The complex etiopathogenesis of focal segmental glomerulosclerosis] 41
Avacopan for the treatment of ANCA-associated vasculitis 41
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response 37
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 36
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype 36
Genetics of ANCA-associated vasculitides: HLA and beyond 36
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) 35
Association of a polymorphism of the Fc gamma-receptor 2A (FCGR2A) gene with chronic periaortitis 33
Variable Expressivity of HNF1B Nephropathy From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease 33
[Anti-SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases. Recommendations of the Italian Society on Nephrology's Working Group on Renal Immunopathology (Vaccine Task Force)] 33
[Peritoneal dialysis: what have we learned from the Covid-19 pandemic?] 33
[ADPKD and intracranial aneurysms: indications for screening, follow-up and clinical management] 31
Editorial: “Toward Precision Medicine in Vasculitis” 30
Correspondence on 'Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 30
[Glomerulonefriti da tossici e farmaci] 30
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? 29
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry 29
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 28
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab 28
[Infection-related glomerulonephritis: the new face of an old disease] 27
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 27
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study. 26
[State of art and new perspectives in the induction regimen of ANCA-associated vasculitis with renal involvement: from histopathology to therapy] 23
Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD 22
The ideal marker for measuring GFR: what are we looking for? 22
Hemodialysis techniques and outcomes in patients with COVID-19: The Brescia experience 21
Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case–Control Study 21
Lessons From the Clinic: ADPKD Genetic Test Unraveling Severe Phenotype, Intrafamilial Variability, and New, Rare Causing Genotype 21
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia 21
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome 20
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 19
Nonlupus Full House Nephropathy 18
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 18
Rituximab in Membranous Nephropathy 18
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 17
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study 13
An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving 12
Sustained post-rituximab B cell depletion is common in ANCA-associated Vasculitis and affected by sex and renal function 12
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 11
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 11
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 10
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 9
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab 9
Peritoneal dialysis discontinuation: to the root of the problem 9
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 8
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases 7
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan 7
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial 7
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 7
Tunneled hemodialysis central venous catheters prevalence and bloodstream infection rates in Northern Italy: A survey of the "East Lombardy Nephrological Network" 7
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 6
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study 6
The paradigm shift in ANCA-associated vasculitis: prime time for the complement targeting 6
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis 5
Covid Pandemic and Kidney Transplantation 5
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 5
Totale 3.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.721
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020828 0 0 0 0 0 0 67 247 224 155 62 73
2020/20211.366 46 88 126 156 124 185 35 134 83 165 114 110
2021/2022600 44 104 22 18 2 64 28 36 37 58 37 150
2022/2023373 83 2 7 7 20 114 0 30 48 2 28 32
2023/2024811 32 30 29 63 53 111 28 34 236 11 26 158
Totale 3.978